RG-HRV16

BIOLOGICAL2 trials

Sponsors

University of Wisconsin, Madison, University of North Carolina, Chapel Hill

Conditions

Healthy VolunteersRhinovirus

Phase 1

A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers

CompletedNCT01769573

University of Wisconsin, MadisonHealthy Volunteers

Start: 2013-07-31End: 2017-12-31Updated: 2019-06-03

Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection

WithdrawnNCT03508479

University of North Carolina, Chapel HillHealthy Volunteers, Rhinovirus

Start: 2024-12-31End: 2026-07-31Updated: 2025-06-03